Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAN007 in Atopic Dermatitis
NCT03000595Phase 2Withdrawn
- Sponsor
- Santalis Pharmaceuticals, Inc.
- Start
- Jun 2018
- Primary completion
- Jan 2019
- Modality
- Transdermal Patches, Hydrogel Systems, Classical Binding Small Molecules
01
Overview
A Phase 2 trial of east indian sandalwood oil cream in atopic dermatitis (AD), sponsored by Santalis Pharmaceuticals, Inc.. Planned start Jun 2018; status: withdrawn.
02
Drugs
east indian sandalwood oil cream
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT03000595.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03000595.